Table 1 General patient data over all advancement flaps
n = 155 | |
|---|---|
Pathogenesis | |
Crohn’s disease | 55 (35) |
Cryptoglandular | 100 (65) |
Fistula course | |
Rectovaginal | 24 (15) |
Transsphincteric | 128 (83) |
Suprasphincteric | 2 (1) |
Intersphincteric | 1 (1) |
Ostomy | 39 (25) |
Age, years | 40 (12–73) |
Sex, female | 71 (46) |
ASA, 1–2 | 144 (93) |
BMI, m2/kg | 25 (17–44) |
Immunosuppressant medication | 41 (26) |
Anti-TNF | 28 (18) |
Anti-Interleukin | 1 (0.5) |
Anti-Integrin | 5 (3) |
Other | 7 (4.5) |
Fistula healing | 86 (56) |
Complications | 9 (5.8) |
Mortality | 0 |
Follow-up, days (95% CI) | 189 (109–269) |